clinicalresearch/PLoS One


71 results

Clearance of asymptomatic P. falciparum Infections Interacts with the number of clones to predict the risk of subsequent malaria in Kenyan children.Liljander A, Bejon P, Mwacharo J, Kai O, Ogada E, Peshu N, Marsh K, Farnert A
PLoS One, (2011). 6:e16940

Mortality in sickle cell anemia in Africa: a prospective cohort study in Tanzania.Makani J, Cox SE, Soka D, Komba AN, Oruo J, Mwamtemi H, Magesa P, Rwezaula S, Meda E, Mgaya J, Lowe B, Muturi D, Roberts DJ, Williams TN, Pallangyo K, Kitundu J, Fegan G, Kirkham FJ, Marsh K, Newton CR
PLoS One, (2011). 6:e14699

Defining clinical malaria: the specificity and incidence of endpoints from active and passive surveillance of children in rural Kenya.Olotu A, Fegan G, Williams TN, Sasi P, Ogada E, Bauni E, Wambua J, Marsh K, Borrmann S, Bejon P
PLoS One, (2010). 5:e15569

Safety of the malaria vaccine candidate, RTS,S/AS01E in 5 to 17 month old Kenyan and Tanzanian Children.Lusingu J, Olotu A, Leach A, Lievens M, Vekemans J, Olivier A, Benns S, Olomi R, Msham S, Lang T, Gould J, Hallez K, Guerra Y, Njuguna P, Awuondo KO, Malabeja A, Abdul O, Gesase S, Dekker D, Malle L, Ismael S, Mturi N, Drakeley CJ, Savarese B, Villafana T, Ballou WR, Cohen J, Riley EM, Lemnge MM, Marsh K, Bejon P, von Seidlein L
PLoS One, (2010). 5:e14090

Iron deficiency and acute seizures: results from children living in rural Kenya and a meta-analysis.Idro R, Gwer S, Williams TN, Otieno T, Uyoga S, Fegan G, Kager PA, Maitland K, Kirkham F, Neville BG, Newton CR
PLoS One, (2010). 5:e14001

Interactions between age and ITN use determine the risk of febrile malaria in children.Bejon P, Ogada E, Peshu N, Marsh K
PLoS One, (2009). 4:e8321

Is audio computer-assisted self-interview (ACASI) useful in risk behaviour assessment of female and male sex workers, Mombasa, Kenya?.van der Elst EM, Okuku HS, Nakamya P, Muhaari A, Davies A, McClelland RS, Price MA, Smith AD, Graham SM, Sanders EJ
PLoS One, (2009). 4:e5340

CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.Karita E, Ketter N, Price MA, Kayitenkore K, Kaleebu P, Nanvubya A, Anzala O, Jaoko W, Mutua G, Ruzagira E, Mulenga J, Sanders EJ, Mwangome M, Allen S, Bwanika A, Bahemuka U, Awuondo K, Omosa G, Farah B, Amornkul P, Birungi J, Yates S, Stoll-Johnson L, Gilmour J, Stevens G, Shutes E, Manigart O, Hughes P, Dally L, Scott J, Stevens W, Fast P, Kamali A
PLoS One, (2009). 4:e4401

Lack of association of interferon regulatory factor 1 with severe malaria in affected child-parental trio studies across three African populations.Mangano VD, Clark TG, Auburn S, Campino S, Diakite M, Fry AE, Green A, Richardson A, Jallow M, Sisay-Joof F, Pinder M, Griffiths MJ, Newton C, Peshu N, Williams TN, Marsh K, Molyneux ME, Taylor TE, Modiano D, Kwiatkowski DP, Rockett KA
PLoS One, (2009). 4:e4206

Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials.Stevens W, Kamali A, Karita E, Anzala O, Sanders EJ, Jaoko W, Kaleebu P, Mulenga J, Dally L, Fast P, Gilmour J, Farah B, Birungi J, Hughes P, Manigart O, Stevens G, Yates S, Thomson H, von Lieven A, Krebs M, Price MA, Stoll-Johnson L, Ketter N
PLoS One, (2008). 3:e2043

Extended follow-up following a phase 2b randomized trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya.Bejon P, Ogada E, Mwangi T, Milligan P, Lang T, Fegan G, Gilbert SC, Peshu N, Marsh K, Hill AV
PLoS One, (2007). 2:e707